RecruitingNCT05342740

Study of Biomarkers in Diabetic Chronic Wounds

A Multicenter Case Control Study of Biomarkers in Diabetic Chronic Wounds Based on Combined Multi-omics Analysis Techniques

Sponsor

Yibing Wang

Enrollment

930 participants

Start Date

Jul 1, 2023

Study Type

OBSERVATIONAL

Conditions

Diabetes Mellitus Biomarker

Summary

This study aims to discover, verify and evaluate the potential biomarkers with regard to the diagnosis, prognostic and/or prediction of diabetic chronic wounds.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria5

Age between 18 and 75;
Signed the informed consent form；
Subjects in the ND group are the healthy participants without diabetes；
Subjects in the NWD group are the diabetic participants without newly identified wounds；
Subjects in the CWD group are the diabetic participants with chronic wounds

Exclusion Criteria2

With sever acute underlying diseases of the brain, heart, lungs, liver and/or kidney;
No diabetes but combined with lower limb arterial stenosis, occlusion or other conditions affecting wound healing or other causes of wounds such as varicose veins in the lower limbs;

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERcollect whole blood, urine and stool samples

collect whole blood, urine and stool samples

Locations(1)

The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital

Jinan, Shandong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05342740

Related Trials

Genetic Studies of Insulin and Diabetes

NCT000019871 location

A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection

NCT074894821 location